Beximco Pharmaceuticals Limited (DSE: BXPHARMA)
Bangladesh
· Delayed Price · Currency is BDT 89.20
+4.70 (5.56%)
At close: Nov 14, 2024
Beximco Pharmaceuticals Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 13, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Market Capitalization | 39,793 | 52,686 | 65,222 | 68,969 | 79,096 | 28,065 | Upgrade
|
| Market Cap Growth | -50.07% | -19.22% | -5.43% | -12.80% | 181.84% | -17.13% | Upgrade
|
| Enterprise Value | 47,384 | 62,322 | 79,259 | 84,113 | 87,267 | 38,810 | Upgrade
|
| Last Close Price | 89.20 | 118.10 | 142.70 | 147.30 | 166.19 | 58.37 | Upgrade
|
| PE Ratio | 6.68 | 9.04 | 13.80 | 12.83 | 14.46 | 7.41 | Upgrade
|
| Forward PE | 5.91 | 8.62 | 12.08 | 10.83 | 16.20 | 7.84 | Upgrade
|
| PS Ratio | 0.89 | 1.19 | 1.66 | 1.99 | 2.68 | 1.10 | Upgrade
|
| PB Ratio | 0.80 | 1.02 | 1.37 | 1.55 | 2.12 | 0.86 | Upgrade
|
| P/TBV Ratio | 0.74 | 1.24 | 1.70 | 1.96 | 2.25 | 0.91 | Upgrade
|
| P/FCF Ratio | 5.86 | 8.27 | 17.75 | 28.75 | 22.58 | 8.51 | Upgrade
|
| P/OCF Ratio | 4.43 | 6.30 | 10.72 | 13.23 | 13.13 | 5.06 | Upgrade
|
| PEG Ratio | 0.31 | 0.98 | 0.98 | 0.98 | 0.98 | 0.51 | Upgrade
|
| EV/Sales Ratio | 1.05 | 1.40 | 2.02 | 2.43 | 2.96 | 1.52 | Upgrade
|
| EV/EBITDA Ratio | 4.67 | 6.25 | 8.84 | 10.20 | 11.70 | 5.98 | Upgrade
|
| EV/EBIT Ratio | 5.55 | 7.52 | 11.48 | 12.78 | 13.75 | 7.22 | Upgrade
|
| EV/FCF Ratio | 8.52 | 9.78 | 21.57 | 35.06 | 24.92 | 11.76 | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.12 | 0.22 | 0.28 | 0.20 | 0.32 | Upgrade
|
| Debt / EBITDA Ratio | 0.49 | 0.60 | 1.18 | 1.50 | 1.02 | 1.62 | Upgrade
|
| Debt / FCF Ratio | 0.89 | 0.95 | 2.89 | 5.16 | 2.18 | 3.18 | Upgrade
|
| Asset Turnover | 0.64 | 0.64 | 0.58 | 0.59 | 0.58 | 0.52 | Upgrade
|
| Inventory Turnover | 1.82 | 1.87 | 1.77 | 1.91 | 2.03 | 1.91 | Upgrade
|
| Quick Ratio | 0.57 | 0.52 | 0.37 | 0.35 | 0.39 | 0.35 | Upgrade
|
| Current Ratio | 2.43 | 2.18 | 1.57 | 1.45 | 1.47 | 1.15 | Upgrade
|
| Return on Equity (ROE) | 11.66% | 11.79% | 9.81% | 12.19% | 14.73% | 11.31% | Upgrade
|
| Return on Assets (ROA) | 7.61% | 7.48% | 6.38% | 6.95% | 7.75% | 6.76% | Upgrade
|
| Return on Capital (ROIC) | 9.18% | 8.92% | 7.49% | 8.06% | 8.98% | 7.75% | Upgrade
|
| Earnings Yield | 14.97% | 11.06% | 7.07% | 7.43% | 6.48% | 12.52% | Upgrade
|
| FCF Yield | 13.98% | 12.09% | 5.63% | 3.48% | 4.43% | 11.75% | Upgrade
|
| Dividend Yield | 4.48% | 3.39% | 2.45% | 2.38% | 2.11% | 2.34% | Upgrade
|
| Payout Ratio | 26.64% | 27.20% | 33.98% | 31.68% | 11.28% | 17.13% | Upgrade
|
| Buyback Yield / Dilution | 0.05% | - | - | - | - | 0.00% | Upgrade
|
| Total Shareholder Return | 4.54% | 3.39% | 2.45% | 2.38% | 2.11% | 2.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.